Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.

KKPCF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$984.59M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Kaken Pharmaceutical Co., Ltd.Kaken Pharmaceutical Co., Ltd.15.84.97%6%--
$28.29

Current Fair Value

8.8% upside

Undervalued by 8.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$984.59 Million
Enterprise Value$-48,689,406,000.00
Annual dividend$1.25
Dividend yield4.97%
Earnings per Share$57.52
Beta0.13
Outstanding Shares37,869,000

Return

Return on Equity5.94%ROE
Return on Assets4.84%
Return on Invested Capital5.64%

Valuation & Multiples

P/E Ratio15.83P/E Ratio
PEG-9.89PEG
Price to Sales0.01Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue1.1
Enterprise Value to EBIT10.32
Enterprise Value to Net Income-6
Total Debt to Enterprise0.04
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 9, 2026
EPS
-$0.07
Est. -$0.03
Revenue
$119.46 M
Est. $132.22 M

Next Earnings Call

Expected Date
February 4, 2027
EPS Estimate
$0.37
Consensus analyst estimate
Revenue Estimate
$136.13 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Kaken Pharmaceutical Co., Ltd.

1,114 employees
CEO: Hiroyuki Horiuchi

Kaken Pharmaceutical Co., Ltd. is involved in the development, manufacturing, and commercialization of a diverse range of medical goods, health devices, and agricultural chemicals, serving both domestic and global markets. Their extensiv...